Drug Shortage Report for PMS-AMLODIPINE-ATORVASTATIN
Report ID | 1726 |
Drug Identification Number | 02404222 |
Brand name | PMS-AMLODIPINE-ATORVASTATIN |
Common or Proper name | Amlodipine-Atorvastatin |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | AMLODIPINE ATORVASTATIN |
Strength(s) | 5MG 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C10BX |
ATC description | LIPID MODIFYING AGENTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2015-07-07 |
Estimated end date | Unknown |
Actual end date | 2020-04-01 |
Shortage status | Resolved |
Updated date | 2020-04-02 |
Company comments | Product to be discontinued. It will be relaunched under new DIN |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-04-02 | French | Compare |
v4 | 2020-04-02 | English | Compare |
v3 | 2017-03-13 | French | Compare |
v2 | 2017-03-13 | English | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 5 of 5